Digest Network Come funziona
Network
/
Società
Dy
Non verificato

Dyno Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaEventiIndustriaSaluteTecnica

14 comunicati stampa

Guarda tutti i comunicati
27/10/2026
Tecnica
Scienza
Biotecnologia
Software
Salute
Farmaceutica
Eventi
Industria
Dyno Therapeutics to Present New AAV Capsid Data Across Three Posters at the 33rd Annual Congress of the European Society of Gene & Cell Therapy
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/10/2026
Fiere
Eventi
Industria
Scienza
Tecnica
Biotecnologia
Software
Farmaceutica
Salute
Dyno Therapeutics Presents New Multi-Mechanism Muscle Capsid Data at the 31st International Congress of the World Muscle Society
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
13/05/2026
Eventi
Industria
Scienza
Biotecnologia
Salute
Farmaceutica
Sanità
Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC)
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
13/05/2026
Industria
Salute
Tecnica
Biotecnologia
Sanità
Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
27/04/2026
Eventi
Salute
Tecnica
Biotecnologia
Farmaceutica
Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/04/2026
Mercato del lavoro
Industria
Salute
Tecnica
Biotecnologia
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
18/03/2026
Eventi
Fiere
Information Technology
Biotecnologia
Tecnica
Salute
Sanità
Farmaceutica
Scienza
Software
Dyno Therapeutics Launches Dyno Psi-Phi, an Agentic AI Suite for Protein Binder Design, at NVIDIA GTC 2026
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/01/2026
Tecnica
Scienza
Biotecnologia
Salute
Farmaceutica
Industria
Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/11/2025
Tecnica
Scienza
Biotecnologia
Medicina - Varie
Salute
Eventi
Industria
Dyno Therapeutics Unveils Best-in-Class Dyno-bn8 AAV Vector for Muscle Gene Therapies, Achieving Therapeutic Delivery With Improved Safety Potential
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/11/2025
Mercato del lavoro
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0